Cargando…
Antifungal chemotherapies and immunotherapies for the future
Human fungal pathogens cause a broad plethora of infections, spanning cutaneous dermatophytoses to invasive infections in immunocompromised hosts. As eukaryotic pathogens are capable of morphotype switching, they present unique challenges both for drug development and the immunological response. Whi...
Autor principal: | Armstrong‐James, Darius |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078527/ https://www.ncbi.nlm.nih.gov/pubmed/36403106 http://dx.doi.org/10.1111/pim.12960 |
Ejemplares similares
-
C‐type lectin receptors in antifungal immunity: Current knowledge and future developments
por: Hatinguais, Remi, et al.
Publicado: (2022) -
Perspectives on the clinical development of immunotherapy in prostate cancer
por: Cordes, Lisa M, et al.
Publicado: (2018) -
Immunotherapy in HIV infection; current and future challenges
por: Lévy, Yves
Publicado: (2010) -
Engineered biomaterials for cancer immunotherapy
por: Cai, Lulu, et al.
Publicado: (2020) -
Immunotherapy and therapeutic vaccines in prostate cancer: an update on current strategies and clinical implications
por: Singh, B Harpreet, et al.
Publicado: (2014)